Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation (vol 10, pg 69, 2019)

被引:0
|
作者
Ling, W.
Shoptaw, S.
Goodman-Meza, D.
机构
来源
关键词
D O I
10.2147/SAR.S247083
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:19 / 20
页数:2
相关论文
共 50 条
  • [21] Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
    Marcus Björnsson
    Chayan Acharya
    Kerstin Strandgården
    Fredrik Tiberg
    Clinical Pharmacokinetics, 2023, 62 : 1427 - 1443
  • [22] Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
    Bjornsson, Marcus
    Acharya, Chayan
    Strandgarden, Kerstin
    Tiberg, Fredrik
    CLINICAL PHARMACOKINETICS, 2023, 62 (10) : 1427 - 1443
  • [23] Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    Haight, Barbara R.
    Learned, Susan M.
    Laffont, Celine M.
    Fudala, Paul J.
    Zhao, Yue
    Garofalo, Amanda S.
    Greenwald, Mark K.
    Nadipelli, Vijay R.
    Ling, Walter
    Heidbreder, Christian
    Andersen, James L.
    Bailey, Genie L.
    Bartley, Scott Robert
    Biunno, Michael J.
    Boyett, Brent
    Carr, Jesse M.
    Cifuentes, Eduardo
    Duarte-Sckell, Sandra Daniela
    Dueno, Otto R.
    Harrison, Boyde J.
    Hassman, David R.
    Hoffman, Kent Steven
    Isacesu, Valentin
    Ishaque, Saleem
    Kakar, Rishi
    Kampman, Kyle
    Knapp, Richard D.
    Konis, George
    Kunovac, Jelena
    Kwentus, Joseph A.
    Levinson, Lawrence S.
    Malhotra, Shishuka
    Mehra, Vishaal
    Mofsen, Ricky Stuart
    Peyton, Marvin Lane
    Pujari, Gita G.
    Ranjan, Rakesh
    Rutrick, Daniel
    Seal, Gregory
    Segal, Scott Daniel
    Shiwach, Rajinder
    Thomas, Haydn Mikel
    Ventre, Peter Paul
    Vijapura, Amit K.
    Walling, David P.
    Wiest, Katharina L.
    LANCET, 2019, 393 (10173): : 778 - 790
  • [24] Changes in associations of prescription opioid use disorder and illegal behaviors among adults in the United States from 2002 to 2014 (vol 2019, pg 2150, 2019)
    Mintz, Carrie M.
    Hartz, Sarah M.
    Borodovsky, Jacob T.
    Bierut, Laura J.
    Grucza, Richard A.
    ADDICTION, 2021, 116 (01) : 214 - 214
  • [25] Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder (vol 186, pg 171, 2018)
    Holt, Stephen R.
    Donroe, Joseph H.
    Cavallo, Dana A.
    Tetrault, Jeanette M.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 205
  • [26] Impact of Medicaid expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment (vol 55, pg 336, 2017)
    Wen, Hefei
    Hockenberry, Jason
    Borders, Tyrone
    Druss, Benjamin
    MEDICAL CARE, 2019, 57 (03) : 243 - 243
  • [28] Managing opioid use disorder in primary care. PEER simplified guideline (vol 65, pg 321, 2019)
    Korownyk, C.
    Perry, D.
    Ton, J.
    Kolber, M. R.
    Garrison, S.
    Thomas, B.
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (10) : 687 - 687
  • [29] Group Well Child Care for Mothers with Opioid Use Disorder: Framework for Implementation (vol 27, pg 75, 2023)
    Goyal, Neera
    Gannon, Meghan
    Sood, Erica
    Harris, Grace
    Franko, Elizabeth
    Abatemarco, Diane J.
    Hand, Dennis J.
    Leib, Susan
    Short, Vanessa L.
    MATERNAL AND CHILD HEALTH JOURNAL, 2024, 28 (03) : 598 - 599
  • [30] Association of Opioid Prescriptions From Dental Clinicians for US Adolescents and Young Adults With Subsequent Opioid Use and Abuse (vol 179, pg 145, 2019)
    Schroeder, A. R.
    Dehghan, M.
    Newman, T. B.
    Bentley, J. P.
    Park, K. T.
    JAMA INTERNAL MEDICINE, 2019, 179 (07) : 1007 - 1007